Regentkit Advantage

  • PRP, PRP-LR, PRP-LP, PRF options
  • Leukocyte Rich and Leukocyte Poor versions available
  • Highest PRP Yield per Blood Draw on the market
  • 8-10mls blood yields 4-5ccs PRP
  • As little as 5 minute processing time
  • Convenience kits available
  • Automatic Blood Draw
  • Automatic Platelet Separation
  • Adjustable concentration 1.7 to 5x over baseline
  • Up to 99.7% RBC removal (bct version)

 

The RegenKit THT Autologous Platelet-rich Plasma (A-PRP) system aids in the separation of the patient’s own blood components through the use of the RegenKit THT vacuum tube and clinical centrifuge. RegenKit THT A-PRP is designed to deliver an increased concentration of bioactive factors and proteins through the concentration of platelets from whole blood. Once the blood is drawn into the RegenKit THT vacuum tube it is then spun under centrifugation according to centrifuge operating instructions. The PRP prepared using the RegenKit THT is a platelet-rich plasma preparation with high platelet recovery and viability, a physiological level of leukocytes, and contains the entire plasma component of blood, which is rich in growth factors. The platelet–rich plasma is collected with syringes and can be mixed during application at the patient’s point of care.

Indications for Use

RegenKit-THT is designed to be used for the safe a rapid perparation of autologous platelet rich-rich plasma (A-PRP) from a small sample of blood at the patient’s point of care. The PRP is mixed with autograft and/or allograft bone prior to application to an orthopaedic surgical site, as deemed necessary by clinical use requirements.

References

  1. Lin MD, et al., Intra-articular Injection of Platelet-Rich Plasma Is Superior to Hyaluronic Acid or Saline Solution in the Treatment of Mild to Moderate Knee Osteoarthritis: A Randomized, Double-Blind, Triple-Parallel, Placebo-Controlled Clinical Trial. Journal of Arthroscopic and Related Suregery, January, 2019, Volume 35, Issue 1, Pages 106–117.
  2. Study Report – Regen™ THT Tube Performance Testing, USFDA 510(k) BK090048, May 2010, Data on file at RegenLab, Switzerland.
  3. Kevy, et al., “Comparison of Methods for Point of Care Preparation of Autologous Platelet Gel”. JECT 36:p. 28 (2004).
  4. S. Arnoczky, “What is Platelet-rich Plasma (PRP)”. AAOS Now 2001 PRP Forum - Agenda and Background Materials, February 14, 2011.
  5. Foster T et al., “Platelet-Rich Plasma - From Basic Science to Clinical Applications”. AJSM 37 (11), p. 2259 (2009).
  6. Platelets, Second Edition, Alan D. Michelson Editor, Elsevier (2007).
  7. Cieslik-Bielecka et al., “Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury”. Transfusion and Apheresis Science 41, p. 9 (2009).
  8. Clark, “Fibrin and Wound Healing”. Annals of New York Academy of Sciences, p. 355 (2001).

Our other biologic product categories...

Acellular Dermal Matrix

Adipose Tissue Treatment

Platelet Rich Plasma

Synthetic Grafts

Wharton's Jelly / Umbilical Cord

Cartilage Repair

Tissue and Bone Banks

Learn more about our products...

Biologics      Shoulder      Knee        Arthroscopy      Distal Extremity      Hip     Suture      Endo Release   Mi-Eye Mi-Ultra     DME